Coronavirus
disease-19
(COVID-19)
causes
immune
perturbations
which
may
persist
long
term,
and
patients
frequently
report
ongoing
symptoms
for
months
after
recovery.
We
assessed
activation
at
3-12
post
hospital
admission
in
187
samples
from
63
with
mild,
moderate,
or
severe
disease
investigated
whether
it
associates
COVID.
At
3
months,
displayed
persistent
of
CD4
Cell,
Journal Year:
2021,
Volume and Issue:
184(19), P. 4953 - 4968.e16
Published: Aug. 19, 2021
Severe
coronavirus
disease
2019
(COVID-19)
is
characterized
by
overproduction
of
immune
mediators,
but
the
role
interferons
(IFNs)
type
I
(IFN-I)
or
III
(IFN-III)
families
remains
debated.
We
scrutinized
production
IFNs
along
respiratory
tract
COVID-19
patients
and
found
that
high
levels
IFN-III,
to
a
lesser
extent
IFN-I,
characterize
upper
airways
with
viral
burden
reduced
risk
severity.
Production
specific
not
members
denotes
mild
pathology
efficiently
drives
transcription
genes
protect
against
severe
acute
syndrome
2
(SARS-CoV-2).
In
contrast,
compared
subjects
other
infectious
noninfectious
lung
pathologies,
are
overrepresented
in
lower
exhibit
gene
pathways
associated
increased
apoptosis
decreased
proliferation.
Our
data
demonstrate
dynamic
SARS-CoV-2-infected
show
play
opposing
roles
at
distinct
anatomical
sites.
BMC Medicine,
Journal Year:
2022,
Volume and Issue:
20(1)
Published: Jan. 14, 2022
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
is
a
highly
infectious
virus
which
responsible
for
the
disease
2019
(COVID-19)
pandemic.
It
increasingly
clear
that
recovered
individuals,
even
those
who
had
mild
COVID-19,
can
suffer
from
persistent
symptoms
many
months
after
infection,
condition
referred
to
as
"long
COVID",
post-acute
sequelae
of
COVID-19
(PASC),
syndrome,
or
post
condition.
However,
despite
plethora
research
on
relatively
little
known
about
molecular
underpinnings
these
long-term
effects.We
have
undertaken
an
integrated
analysis
immune
responses
in
blood
at
transcriptional,
cellular,
and
serological
level
12,
16,
24
weeks
post-infection
(wpi)
69
patients
recovering
mild,
moderate,
severe,
critical
comparison
healthy
uninfected
controls.
Twenty-one
were
long
COVID
clinic
>
50%
reported
ongoing
more
than
6
post-infection.Anti-Spike
anti-RBD
IgG
largely
stable
up
wpi
correlated
with
severity.
Deep
immunophenotyping
revealed
significant
differences
multiple
innate
(NK
cells,
LD
neutrophils,
CXCR3+
monocytes)
adaptive
populations
(T
helper,
T
follicular
regulatory
cells)
convalescent
individuals
compared
controls,
most
strongly
evident
12
16
wpi.
RNA
sequencing
perturbations
gene
expression
convalescents
until
least
post-infection.
We
also
uncovered
transcriptome
not.Variation
rate
recovery
infection
cellular
transcriptional
may
explain
persistence
associated
some
individuals.
Nature reviews. Immunology,
Journal Year:
2021,
Volume and Issue:
22(1), P. 7 - 18
Published: Dec. 6, 2021
The
germinal
centre
(GC)
response
is
critical
for
the
generation
of
affinity-matured
plasma
cells
and
memory
B
capable
mediating
long-term
protective
immunity.
Understanding
whether
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
infection
or
vaccination
elicits
a
GC
has
profound
implications
capacity
responding
to
contribute
protection
against
infection.
However,
direct
assessment
in
humans
remains
major
challenge.
Here
we
summarize
emerging
evidence
importance
establishment
durable
broad
immunity
SARS-CoV-2
discuss
new
approaches
modulate
better
protect
newly
variants.
We
also
findings
showing
that
cell
persists
draining
lymph
nodes
at
least
6
months
some
individuals
following
with
mRNA-based
vaccines.
In
this
Review,
Brian
Laidlaw
Ali
Ellebedy
outline
our
current
understanding
its
establishing
virus.
They
consider
responses
seen
how
may
be
modulated
induce
variants
SARS-CoV-2.
Immunological Reviews,
Journal Year:
2022,
Volume and Issue:
310(1), P. 27 - 46
Published: June 22, 2022
Immunological
memory
is
the
basis
of
protective
immunity
provided
by
vaccines
and
previous
infections.
can
develop
from
multiple
branches
adaptive
immune
system,
including
CD4
T
cells,
CD8
B
long-lasting
antibody
responses.
Extraordinary
progress
has
been
made
in
understanding
to
SARS-CoV-2
infection
COVID-19
vaccines,
addressing
development;
quantitative
qualitative
features
different
cellular
anatomical
compartments;
durability
each
component
antibodies.
Given
sophistication
measurements;
size
human
studies;
use
longitudinal
samples
cross-sectional
head-to-head
comparisons
between
or
for
1
year
already
supersedes
that
any
other
acute
infectious
disease.
This
knowledge
may
help
inform
public
policies
regarding
as
well
scientific
development
future
against
diseases.
Cell,
Journal Year:
2021,
Volume and Issue:
185(3), P. 493 - 512.e25
Published: Dec. 28, 2021
Severe
COVID-19
is
linked
to
both
dysfunctional
immune
response
and
unrestrained
immunopathology,
it
remains
unclear
whether
T
cells
contribute
disease
pathology.
Here,
we
combined
single-cell
transcriptomics
proteomics
with
mechanistic
studies
assess
pathogenic
cell
functions
inducing
signals.
We
identified
highly
activated
CD16
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2022,
Volume and Issue:
12
Published: June 30, 2022
The
duration
and
severity
of
COVID-19
are
related
to
age,
comorbidities,
cytokine
synthesis.
This
study
evaluated
the
impact
these
factors
on
patients
with
clinical
presentations
in
a
Brazilian
cohort.
A
total
317
diagnosed
were
included;
cases
distributed
according
status
as
severe
(n=91),
moderate
(n=56)
mild
(n=170).
Of
patients,
92
had
acute
at
sample
collection,
90
already
recovered
from
without
sequelae,
135
sequelae
(long
COVID
syndrome).
In
group,
form
higher
IL-6
levels
(p=0.0260).
post-COVID-19
there
was
no
significant
difference
between
groups
different
conditions.
younger
TNF-α,
comorbidities
IL-4
IL-2
(p<0.05).
contrast,
over
age
60
IL-6.
subjects
long
IL-17
(p<0.05),
IL-10,
IL-
4
Our
results
suggest
that
advanced
elevated
serum
associated
good
markers
differentiate
cases.
Furthermore,
high
low
IL-10
appear
constitute
profile
COVID-19,
potential
targets
for
treatment
prevention
strategies.
Proceedings of the National Academy of Sciences,
Journal Year:
2022,
Volume and Issue:
119(15)
Published: April 6, 2022
The
emergence
of
SARS-CoV-2
triggering
the
COVID-19
pandemic
ranks
as
arguably
greatest
medical
emergency
last
century.
has
highlighted
health
disparities
both
within
and
between
countries
will
leave
a
lasting
impact
on
global
society.
Nonetheless,
substantial
investment
in
life
sciences
over
recent
decades
facilitated
rapid
scientific
response
with
innovations
viral
characterization,
testing,
sequencing.
Perhaps
most
remarkably,
this
permitted
development
highly
effective
vaccines,
which
are
being
distributed
globally
at
unprecedented
speed.
In
contrast,
drug
treatments
for
established
disease
have
delivered
limited
benefits
so
far.
Innovative
approaches
design
execution
large-scale
clinical
trials
repurposing
existing
drugs
saved
many
lives;
however,
more
remain
risk.
review
we
describe
challenges
unmet
needs,
discuss
therapeutics,
address
future
opportunities.
Consideration
is
given
to
factors
that
hindered
order
support
planning
next
challenge
allow
cost-effective
new
therapeutics
equitable
delivery.